GoKawiil
Tech News
Researchers analyzed tumor-draining lymph nodes from melanoma and non-small cell lung cancer patients, comparing those with early disease recurrence to those without, using tissue collected during routine diagnostic procedures at Erasmus MC. The study identifies the enzyme PLA2G2D as a regulator within these lymph nodes that influences how effectively the immune system mounts a response against tumors.
Researchers identified a class of long-range GABAergic (Sst+/Nos1+) inhibitory neurons in the mouse neocortex that project across distant cortical regions rather than staying local. Using genetic mouse models, in vivo imaging and chemogenetic manipulation, they showed these neurons drive widespread cortical synchrony and are linked to sleep regulation.
Researchers analyzed genome-wide data from over 140,000 participants in the Mexico City Prospective Study, combining it with reference panels from the 1000 Genomes Project and Human Genome Diversity Project to estimate individual ancestry proportions across Indigenous American, European, African and East Asian populations. Using an ADMIXTURE model with four ancestral groups, they examined how differences in ancestry proportions among siblings within the same family relate to complex traits, isolating genetic ancestry effects from shared environmental and socioeconomic factors.
Scientists have developed a drug delivery approach that targets specific structures within individual cells rather than simply reaching a cell as a whole. This subcellular precision aims to route therapeutic payloads to particular organelles or compartments where they can act most effectively.
Scientists are developing intranasal vaccines designed to trigger immunity directly in the nose and upper airway, the entry point for many respiratory pathogens. Unlike injected vaccines that mainly prevent severe illness, these formulations aim to stop infection and transmission before a virus can spread further.
Researchers are redesigning drug molecules and delivery systems so a single injection or implant can maintain therapeutic effects for weeks, months, or even years instead of requiring daily dosing. Techniques include chemical modifications that slow drug breakdown, polymer depots, and implantable devices that release medication gradually over extended periods.
A Nature piece argues that even well-designed drugs fail patients if they cannot reach the intended biological target effectively. The commentary highlights delivery mechanisms and targeting accuracy as critical, often underappreciated, factors in therapeutic success.
A Nature editorial argues that a substantial share of prescribed medicines fail to help patients simply because they are not taken as directed. It calls for more research and health-system attention on why patients skip or stop treatments, rather than focusing solely on drug development.
Researchers at the University of Minnesota, led by surgeon Daniel Saltzman, have developed a therapy using genetically modified Salmonella Typhimurium bacteria to carry interleukin-2, an immune-stimulating molecule, straight into tumours. Pancreatic cancer patient John Heller received the experimental treatment after starting chemotherapy for advanced disease, illustrating an early real-world test of the approach.
A Nature feature surveys six novel approaches under development for delivering drugs more precisely and effectively, ranging from advanced nanoparticle carriers to devices designed to target specific tissues. These innovations aim to overcome longstanding challenges such as poor bioavailability, degradation before reaching target sites, and off-target side effects.
Scientists are developing genetically modified bacteria designed to seek out and treat tumors from within the body. The approach relies on engineering microbes to recognize cancerous tissue and deliver therapeutic effects directly at the tumor site.
A new speculative fiction piece from Nature Futures follows Melba, an employee managing the Lost Luggage Department at a nearly abandoned interstellar flight headquarters. The story details how travelers' bags are shrunk via molecular-reduction technology before space voyages, and how some end up misrouted for decades, eventually landing in Melba's basement office filled with stacks of miniaturized suitcases.